Ralph Weissleder

Harvard University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

200h-index170.3kcitations1.6kworks3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced biosensing and bioanalysis techniques(133), Nanoplatforms for cancer theranostics(123), Monoclonal and Polyclonal Antibodies Research(108), Extracellular vesicles in disease(107), Advanced Fluorescence Microscopy Techniques(97)

Publications1.6k total

Targeting myeloid cell polarization to prevent GBM recurrence
Molecular Therapy·2025Open Access
Integrated Multi‐Channel Automatic Cellular Profiling (iMAP) System for Cholangiocarcinoma Diagnosis
Small·2025Open Access
Therapeutic Targeting of Epithelial–Mesenchymal Cellular Plasticity in Pancreatic Cancer
Clinical Cancer Research·2025
Supplementary Figure S6 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
2025Open Access
Supplementary Figure S5 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
2025Open Access
Supplementary Figure S4 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
2025Open Access
Supplementary Figure S3 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
2025Open Access
Supplementary Table S2 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
2025Open Access
Supplementary Figure S2 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
2025Open Access
Supplementary Table S1 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
2025Open Access
Supplementary Figure S1 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
2025Open Access
Next-Generation Approaches to Improve the Information Content of Interventional Radiology Biopsies
Journal of Vascular and Interventional Radiology·2025Open Access
Targeting cancer-associated fibroblasts for real-time intraoperative tumor identification with a spray-on fluorescent probe
Science Advances·2025Open Access
93 Spatial analysis of head and neck squamous cell cancer tumor microenvironment identifies predictors of pembrolizumab therapy
Regular and Young Investigator Award Abstracts·2025Open Access
Far-Red Spray-On Imaging Probes for FAP-Targeted Cancer Surgery
Bioconjugate Chemistry·2025
Outcomes of Percutaneous Cystic Duct Stent Placement for Acute Cholecystitis
Journal of Vascular and Interventional Radiology·2025
Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence
Nature Biomedical Engineering·2025· 3 citedOpen Access
Genetically engineered organs for early reporting of transplant rejection
Molecular Therapy·2025Open Access
Radiation-Triggered Payload Release Enhances Bispecific Antibody Efficacy
Cancer Research·2025· 1 cited
A Myeloid Cell-Targeted Immunostimulant Cocktail (MyTai) Enhances Cancer Immunotherapy
ACS Nano·2025
page 1 of 80Next →

Frequent Co-authors

Mikäel J. Pittet(12), Matthias Nahrendorf(10), Filip K. Świrski(10), Peter Libby(8), Yoshiko Iwamoto(7), Ching‐Hsuan Tung(5), Umar Mahmood(5), Elena Aïkawa(4), Jose‐Luiz Figueiredo(4), Virna Cortez‐Retamozo(4), Rainer H. Köhler(4), Vasilis Ntziachristos(4), Hakho Lee(4), Gabriel Courties(4), Rostic Gorbatov(4), Lee Josephson(4), Martin Etzrodt(3), Alexander R. Guimarães(3), Huilin Shao(3), Claudio Vinegoni(3)